We are live on
!
Find out more
EMR
Errol M. Rudman Portfolio holdings
AUM
$148M
1-Year Est. Return
19.65%
This Fund
S&P 500
This Quarter
Est. Return
+12.88%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$53M
(+25%)
Cap. Flow
+$32.9M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
51.87%
Holding
53
New
10
Increased
9
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$6.65M |
| 2 |
JPMorgan Chase
JPM
|
+$6.24M |
| 3 |
Addus HomeCare
ADUS
|
+$4.21M |
| 4 |
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
|
+$4.02M |
| 5 |
Wells Fargo
WFC
|
+$3.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BLD
TopBuild
BLD
|
+$4.23M |
| 2 |
Dentsply Sirona
XRAY
|
+$2.08M |
| 3 |
ESPR
Esperion Therapeutics
ESPR
|
+$1.96M |
| 4 |
Cal-Maine
CALM
|
+$1.52M |
| 5 |
Lazard
LAZ
|
+$1.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 32.5% |
| 2 | Healthcare | 26.43% |
| 3 | Financials | 9.91% |
| 4 | Consumer Discretionary | 7.8% |
| 5 | Technology | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
TransDigm Group
TDG
$67.4B
| $33.4M | 12.47% |
89,736
-580
| -0.6% | -$209K |
|
2
Centene
CNC
$32.5B
| $21.6M | 8.06% |
298,400
| – | – |
|
3
United Airlines
UAL
$38.1B
| $20M | 7.47% |
224,783
| – | – |
|
4
Delta Air Lines
DAL
$55.6B
| $11.7M | 4.37% |
202,410
| – | – |
|
5
HCA Healthcare
HCA
$82.2B
| $11.1M | 4.15% |
79,970
| – | – |
|
6
Cigna
CI
$75.1B
| $8.96M | 3.34% |
43,000
| – | – |
|
|
ESRX
7
DELISTED
Express Scripts Holding Company
ESRX
| $8.9M | 3.32% |
93,726
| – | – |
|
8
Mohawk Industries
MHK
$6.58B
| $8.1M | 3.02% |
46,200
+7,000
| +18% | +$1.37M |
|
9
Lumen
LUMN
$6.57B
| $7.74M | 2.89% |
364,841
| – | – |
|
10
Wabtec
WAB
$43.8B
| $7.39M | 2.76% |
70,500
+17,000
| +32% | +$1.83M |
|
11
MongoDB
MDB
$26B
| $7.01M | 2.62% |
86,000
| – | – |
|
|
CBPO
12
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $6.4M | 2.39% |
80,000
+71,334
| +823% | +$6.65M |
|
|
13
JPMorgan Chase
JPM
$901B
| $6.21M | 2.32% |
+55,000
| New | +$6.24M |
|
14
Rush Enterprises Class A
RUSHA
$5.82B
| $5.7M | 2.13% |
326,250
+78,750
| +32% | +$1.5M |
|
15
Rockwell Automation
ROK
$51B
| $5.63M | 2.1% |
30,000
| – | – |
|
16
CVS Health
CVS
$137B
| $5.57M | 2.08% |
70,704
| – | – |
|
|
BFYT
17
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $5.43M | 2.03% |
+88,108
| New | +$4.02M |
|
18
Goldman Sachs
GS
$311B
| $4.56M | 1.7% |
20,340
| – | – |
|
|
19
Addus HomeCare
ADUS
$2.08B
| $4.56M | 1.7% |
+65,000
| New | +$4.21M |
|
20
Floor & Decor
FND
$5.82B
| $4.43M | 1.65% |
146,895
+30,000
| +26% | +$1.22M |
|
21
iShares Biotechnology ETF
IBB
$9.23B
| $4.27M | 1.59% |
35,000
| – | – |
|
22
Molina Healthcare
MOH
$12B
| $4.21M | 1.57% |
28,300
| – | – |
|
|
ZAYO
23
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $4.13M | 1.54% |
119,000
+20,000
| +20% | +$730K |
|
|
CCMP
24
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $4.02M | 1.5% |
39,000
+15,000
| +63% | +$1.69M |
|
25
Meta Platforms (Facebook)
META
$1.64T
| $3.83M | 1.43% |
23,300
+8,300
| +55% | +$1.5M |
|
Similar funds
HAM
TAM
RMPT
QAM
CWM
RCA
CI
LS
Errol M. Rudman's Q3 2018 Portfolio in Review
As of Q3 2018, Errol M. Rudman held 53 positions worth $268M, up 25% from $215M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Errol M. Rudman deployed $32.9M of net new capital in Q3 2018, opening 10 new positions and adding to 9 existing holdings. Its largest new stake was JPMorgan Chase: 55,000 shares worth $6.21M.
By sector, the portfolio is most concentrated in Industrials at 33% of assets, down from 36% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Dentsply Sirona, an estimated $2.08M trimmed.
- Errol M. Rudman's largest Q3 2018 buy was JPMorgan Chase: 55,000 shares worth $6.21M.
- Errol M. Rudman added most to China Biologic Products Holdings, Inc. in Q3 2018, an estimated $6.65M increase.
- Errol M. Rudman's biggest Q3 2018 reduction was Dentsply Sirona, cutting an estimated $2.08M.
- Errol M. Rudman fully exited TopBuild in Q3 2018, selling an estimated $4.23M.
- Errol M. Rudman's ten largest holdings make up 52% of its $268M portfolio in Q3 2018.
- Errol M. Rudman opened 10 new positions and closed 3 in Q3 2018.
- Errol M. Rudman's portfolio value rose 25% quarter-over-quarter to $268M.
Based on Errol M. Rudman's 13F filing for Q3 2018, filed 14 Nov 2018.